Healthcare Latest news, Medical Technology Updated News
Herbal medicines, have always been an integral part of our culture. The roots of which can be traced back to thousands of years. The medical field has evolved in a drastic manner over the years. In a way the foundation…
TOKYO — Japan will perform full-genome analysis on medical samples from as many as 93,000 people under an action plan revealed by the country’s health ministry.The blood, cancer cells and other samples are held at hospital and research institute biobanks…
It was found by the Japanese Researchers that over the last two years, the rate of relapse was relatively high in ulcerative colitis patients who receive the corticosteroid budesonide in topical rectal foam inclusive of those who previously had achieved…
The Japanese Cancer Association (JCA) is the longest-running association committed to malignant growth look into in Japan. The association is worried about all components of malignant growth examine, including essential, clinical and translational examination into the etiology, avoidance, conclusion and…
The Chief Executive Officer and Chairman of Rakuten Medical Inc., Hiroshi Mikitani, has announced results of an early clinical study of the bio-venture company’s photoimmunotherapy therapy for patients with advanced stage head and neck cancers in Tokyo on July 1.…
PPD-SNBL, which is the joint venture of Shin Nippon Biomedical Laboratories which is Japan’s largest clinical development service supplier, and Pharmaceutical Product Development LLC which is a pioneering international contract research firm, has been enlisted amongst the top 5 advance…
An announcement was made today by QIAGEN that its QIAGEN Clinical Insight offering was chosen by the Japan’s National Cancer Center, as a part of the program of Ministry of Labor, Health and Welfare’s precision medicine program of Japan, for…
A Japanese government board endorsed on Wednesday a cost of 33.5 million yen ($305,800) for Novartis’ malignant growth treatment Kymriah, permitting the Swiss drugmaker to press ahead with a crusade to kick-begin lazy offers of the treatment. The one-time, customized…